Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 6—June 2026
Research
Role of Households with Children in Community Spread of Multidrug-Resistant Enterobacterales, St. Louis, Missouri, USA
Table 3
Klebsiella pneumoniae characteristics by isolate source in study of role of households with children in community spread of multidrug-resistant Enterobacterales, St. Louis, Missouri, USA*
| Characteristic | Total, n = 10 | Environmental source, n = 7 | Human source, n = 3 |
|---|---|---|---|
| MLST | |||
| Unknown | 2 (20) | 2 (29) | 0 |
| 1380 | 1 (10) | 1 (14) | 0 |
| 20 | 1 (10) | 1 (14) | 0 |
| 29 | 2 (20) | 1 (14) | 1 (33) |
| 461 | 1 (10) | 1 (14) | 0 |
| 466 | 1 (10) | 1 (14) | 0 |
| 678 |
2 (20) |
0 |
2 (67) |
| Median AMR gene count per isolate (IQR) |
5 (4.25–5) |
5 (3.5–5) |
5 (5–5.5) |
| AMR resistance determinants | |||
| β-lactam AMR determinants | 10 (100) | 32 (100) | 15 (100) |
| blaSHV, unspecified | 2 (20) | 1 (14) | 1 (33) |
| blaSHV-1 | 1 (10) | 1 (14) | 0 |
| blaSHV-187 | 1 (10) | 1 (14) | 0 |
| blaSHV-26 | 1 (10) | 1 (14) | 0 |
| blaSHV-33 | 1 (10) | 1 (14) | 0 |
| blaSHV-36 | 2 (20) | 2 (29) | 0 |
| blaSHV-41 | 2 (20) | 0 | 2 (67) |
| blaTEM-10 | 2 (20) | 1 (14) | 1 (33) |
| Fosfomycin AMR determinants | 10 (100) | 7 (100) | 3 (100) |
| fosA | 6 (60) | 3 (43) | 3 (100) |
| fosA10 | 4 (40) | 4 (57) | 0 |
| Multiclass AMR determinants | |||
| emrD | 10 (100) | 7 (100) | 3 (100) |
| Phenicol/quinolone AMR determinants | 7 (70) | 4 (57) | 3 (100) |
| oqxA | 3 (30) | 2 (29) | 1 (33) |
| oqxA3 | 1 (10) | 1 (14) | 0 |
| oqxA10 | 3 (30) | 1 (14) | 2 (67) |
| oqxB | 2 (20) | 0 | 2 (67) |
| oqxB19 | 2 (20) | 2 (29) | 0 |
| oqxB25 | 3 (30) | 2 (29) | 1 (33) |
| Trimethoprim AMR determinants | 1 (10) | 1 (14) | 0 |
| dfrA50 |
1 (10) |
1 (14) |
0 |
| Median plasmid count per isolate (IQR) |
3.5 (3–4.75) |
4 (3.5–5) |
3 (2–3) |
| Plasmids | |||
| Col440I | 5 (50) | 5 (71) | 0 |
| Col440II | 3 (30) | 3 (43) | 0 |
| IncFIB(K) | 10 (100) | 7 (100) | 3 (100) |
| IncFIB(Mar) | 1 (10) | 1 (14) | 0 |
| IncFIB(pKPHS1) | 1 (10) | 1 (14) | 0 |
| IncFIB(pQil) | 1 (10) | 1 (14) | 0 |
| IncFII | 3 (30) | 1 (14) | 2 (67) |
| IncFII(K) | 8 (80) | 6 (86) | 2 (67) |
| IncFII(Yp) | 1 (10) | 1 (14) | 0 |
| IncHI1B | 1 (10) | 1 (14) | 0 |
| IncR | 2 (20) | 2 (29) | 0 |
| IncX5 | 1 (10) | 1 (14) | 0 |
| repA | 2 (20) | 1 (14) | 0 |
*Values are no. (%) except as indicated. AMR, antimicrobial resistance; IQR, interquartile range; MLST, multilocus sequence type.
1These first authors contributed equally to this article.
Page created: April 29, 2026
Page updated: May 20, 2026
Page reviewed: May 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.